12 employees
Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.
2022
$15M
from 4 investors over 4 rounds
Constructive Bio raised $15M on August 15, 2022
Investors: OMX Ventures, Amadeus Capital Partners, General Inception and Ahren Innovation Capital